World Journal for Pediatric and Congenital Heart Surgery · 2019 · 14 citations · 34 references
MedicinePediatricsSurgeryCardiothoracic SurgeryPediatric CardiologyReconstructive SurgeryPediatric Cardiac SurgeryPericardial SurgeryEpoxy ResinsExperimental StudiesHeart Valve ReconstructionPericardial ReconstructionPropensity Score AdjustmentRight Ventricular Outflow Tract ObstructionRight Ventricular Outflow Tract Reconstruction
BACKGROUND: Xenografts used for right ventricular outflow tract (RVOT) reconstruction are typically treated with glutaraldehyde. However, potential benefit of epoxy treatment was demonstrated in experimental studies. We aimed to compare diepoxy-treated bovine pericardial valved conduits (DE-PVCs) and glutaraldehyde-treated bovine pericardial valved conduits (GA-PVCs) for RVOT reconstruction in pediatric patients. METHODS: Between 2002 and 2017, 117 patients underwent RVOT reconstruction with PVC in single center: DE-PVC group, n = 39; and GA-PVC group, n = 78. After performing propensity score analysis (1:1) for the entire sample, 29 patients from the DE-PVC group were matched with 29 patients from the GA-PVC group. RESULTS: = .037). Conduit failure was typically caused by stenosis in both groups. In the DE-PVC group, the main cause of stenosis was xenograft calcification (27.6%); while in the GA-PVC group, it was mostly due to neointimal proliferation (25.0%) and, less often, calcification (14.3%). Conduit thrombosis was the cause of replacement in 6.9% of patients from the GA-PVC group. CONCLUSIONS: Diepoxy-treated bovine pericardial valved conduit is a suitable alternative to GA-PVC for RVOT reconstruction in pediatric patients. Diepoxy-treated bovine pericardial valved conduits may be less prone to conduit failure and more resistant to neointimal proliferation and conduit thrombosis than GA-PVCs.
34
Helmut Baumgartner, Philipp Bonhoeffer, N M S De Groot et al. · European Heart Journal · 2010 · 2.3K citations · Full text
Medicine, Cardiology, Pediatrics +9